Nascent BiotechNBIO 
$0.050.00%24h
0.00%24h
Global rank33536
Market cap$5.58M
Change 7d12.95%
YTD Performance-73.83%
SP500 benchmarkUnderperform
P/E-2.35
P/S0
Revenue$0
Earnings-$2.80M
Dividend yield-
Main Sector
Healthcare
EPS for Nascent Biotech (NBIO)
Nascent Biotech has an EPS of $-0.02. In 2022, the company made an earnings per share (EPS) of $-0.004366. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for NBIO
-
Value:-
EPS history for Nascent Biotech from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$0.02 | 358.09% |
| 2022 | -$0.004366 | -56.34% |
| 2021 | -$0.01 | -91.67% |
| 2020 | -$0.12 | - |
View the highest EPS stocks
